Stockreport

DBV Technologies S.A. (DBVT) Discusses Positive Phase III VITESSE Trial Results for Peanut Allergy Patch in Young Children Transcript [Seeking Alpha]

DBV Technologies S.A. - American Depositary Shares  (DBVT) 
US:NASDAQ Investor Relations: dbv-technologies.com/en/investor-relations
PDF Company Participants Jonathan Neely Daniel Tassé - CEO & Director Pharis Mohideen - Chief Medical Officer Kevin Trapp - Chief Commercial Officer Conference Ca [Read more]